Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Read
4196
Timeswas read the article
1120
Total PDF
3076
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 5 | 4 | 9 |
| 2025 April | 101 | 20 | 121 |
| 2025 March | 125 | 32 | 157 |
| 2025 February | 82 | 37 | 119 |
| 2025 January | 66 | 32 | 98 |
| 2024 December | 42 | 36 | 78 |
| 2024 November | 74 | 44 | 118 |
| 2024 October | 24 | 20 | 44 |
| 2024 September | 46 | 21 | 67 |
| 2024 August | 70 | 38 | 108 |
| 2024 July | 56 | 35 | 91 |
| 2024 June | 67 | 29 | 96 |
| 2024 May | 61 | 18 | 79 |
| 2024 April | 55 | 24 | 79 |
| 2024 March | 75 | 24 | 99 |
| 2024 February | 49 | 27 | 76 |
| 2024 January | 84 | 21 | 105 |
| 2023 December | 65 | 30 | 95 |
| 2023 November | 69 | 31 | 100 |
| 2023 October | 76 | 29 | 105 |
| 2023 September | 94 | 43 | 137 |
| 2023 August | 45 | 13 | 58 |
| 2023 July | 56 | 26 | 82 |
| 2023 June | 38 | 35 | 73 |
| 2023 May | 51 | 24 | 75 |
| 2023 April | 34 | 19 | 53 |
| 2023 March | 66 | 26 | 92 |
| 2023 February | 49 | 30 | 79 |
| 2023 January | 33 | 15 | 48 |
| 2022 December | 78 | 50 | 128 |
| 2022 November | 77 | 37 | 114 |
| 2022 October | 108 | 32 | 140 |
| 2022 September | 95 | 37 | 132 |
| 2022 August | 85 | 38 | 123 |
| 2022 July | 72 | 43 | 115 |
| 2022 June | 82 | 44 | 126 |
| 2022 May | 81 | 40 | 121 |
| 2022 April | 54 | 2 | 56 |
| 2022 March | 56 | 2 | 58 |
| 2022 February | 55 | 2 | 57 |
| 2022 January | 220 | 2 | 222 |
| 2021 December | 203 | 4 | 207 |
| 2021 November | 52 | 4 | 56 |
Show all
